×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Versant Venture Capital Vi, L.P.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 18, 2025Sale$38.5615,085581,694962,878Aug 19, 2025, 04:51 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 15, 2025Sale$39.50145,0515,729,5151,430,848Aug 19, 2025, 04:51 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 15, 2025Sale$39.5069,9492,762,986977,963Aug 19, 2025, 04:51 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 18, 2025Sale$38.5630,6281,181,0491,400,220Aug 19, 2025, 04:51 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJul 10, 2025Sale$34.00191,3766,506,7841,575,899Jul 14, 2025, 04:50 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 27, 2025Sale$30.47200,0006,093,0001,767,275Jul 01, 2025, 06:16 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 18, 2025Sale$29.95100,0002,995,0001,148,789Jun 20, 2025, 05:50 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 20, 2025Sale$30.25133,9244,051,2011,967,275Jun 20, 2025, 05:50 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 20, 2025Sale$30.35100,8773,061,6171,047,912Jun 20, 2025, 05:50 PM
LENZLENZ Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 10, 2025Sale$29.00350,00010,150,0001,248,789Jun 12, 2025, 04:37 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 28, 2024Sale$9.6689,990869,2402,007,948Oct 30, 2024, 04:35 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 29, 2024Sale$9.1667,905621,8011,589,053Oct 30, 2024, 04:35 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerSep 20, 2024Sale$6.531,132,5667,395,2035,099,336Sep 24, 2024, 04:40 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerSep 11, 2024Sale$6.00541,8973,251,3826,257,218Sep 13, 2024, 06:44 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerSep 12, 2024Sale$6.0016,04796,3096,241,171Sep 13, 2024, 06:44 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerSep 13, 2024Sale$6.169,26957,1006,231,902Sep 13, 2024, 06:44 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 28, 2024Sale$6.32221,6001,400,5563,726,341Aug 30, 2024, 04:16 PM
TPSTTempest Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 08, 2024Sale$1.35400,000540,040597,940Aug 12, 2024, 08:33 PM
TPSTTempest Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 12, 2024Sale$1.10387,999426,993209,941Aug 12, 2024, 08:33 PM
CTNMContineum Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerApr 09, 2024Conversion-542,628-391,785Apr 11, 2024, 06:10 PM
IPSCCentury Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 09, 2022Sale$13.03550,0007,166,61011,816,814Aug 11, 2022, 04:55 PM
GRPHGraphite Bio, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 29, 2021Buy$17.00180,0003,060,0001,707,719Jul 01, 2021, 07:01 PM
GRPHGraphite Bio, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 29, 2021Conversion-12,343,727-14,708,398Jul 01, 2021, 07:01 PM
GRPHGraphite Bio, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 29, 2021Conversion-1,527,719-1,527,719Jul 01, 2021, 07:01 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 28, 2021Conversion-6,515,869-6,799,115Jun 30, 2021, 05:00 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 28, 2021Conversion-1,940,043-1,940,043Jun 30, 2021, 05:00 PM
GLUEMonte Rosa Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 28, 2021Buy$19.00157,8953,000,0052,097,938Jun 30, 2021, 05:00 PM
IPSCCentury Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 22, 2021Buy$20.00100,0002,000,000714,095Jun 23, 2021, 04:30 PM
IPSCCentury Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 22, 2021Conversion-9,936,011-12,916,814Jun 23, 2021, 04:30 PM
IPSCCentury Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJun 22, 2021Conversion-614,095-614,095Jun 23, 2021, 04:30 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 30, 2020Sale$33.1510,393344,513874,299Dec 01, 2020, 07:13 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 19, 2020Sale$33.0115,163500,531968,954Nov 23, 2020, 04:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 19, 2020Sale$33.01114,8543,791,3304,818,600Nov 23, 2020, 04:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 17, 2020Sale$33.053,705122,4504,933,927Nov 19, 2020, 09:19 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 17, 2020Sale$33.0548916,161984,180Nov 19, 2020, 09:19 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 18, 2020Sale$33.0947315,6534,933,454Nov 19, 2020, 09:19 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 18, 2020Sale$33.09632,085984,117Nov 19, 2020, 09:19 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 16, 2020Sale$33.0123759984,669Nov 17, 2020, 07:33 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 13, 2020Sale$33.773,975134,2534,939,311Nov 17, 2020, 07:33 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 13, 2020Sale$33.7752517,731984,890Nov 17, 2020, 07:33 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 16, 2020Sale$33.011775,8434,937,632Nov 17, 2020, 07:33 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 12, 2020Sale$34.1513,779470,5264,951,587Nov 13, 2020, 07:47 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 12, 2020Sale$34.151,81962,116986,512Nov 13, 2020, 07:47 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 10, 2020Sale$33.8323,821805,7555,669,956Nov 12, 2020, 05:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 10, 2020Sale$33.833,145106,381990,149Nov 12, 2020, 05:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 11, 2020Sale$34.7311,146387,1275,655,404Nov 12, 2020, 05:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 11, 2020Sale$34.731,47151,091988,227Nov 12, 2020, 05:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 09, 2020Sale$33.0673524,296991,652Nov 10, 2020, 07:24 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 06, 2020Sale$33.132,73890,7065,686,909Nov 10, 2020, 07:24 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 06, 2020Sale$33.1336211,993992,387Nov 10, 2020, 07:24 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 09, 2020Sale$33.065,565183,9545,681,344Nov 10, 2020, 07:24 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 04, 2020Sale$33.142929,676993,781Nov 06, 2020, 04:44 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 05, 2020Sale$33.157,816259,0795,689,647Nov 06, 2020, 04:44 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 05, 2020Sale$33.151,03234,208992,749Nov 06, 2020, 04:44 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerNov 04, 2020Sale$33.142,20873,1645,697,463Nov 06, 2020, 04:44 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 26, 2020Sale$33.307,158238,3945,700,378Oct 28, 2020, 05:58 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 26, 2020Sale$33.3094531,473994,166Oct 28, 2020, 05:58 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 27, 2020Sale$33.0370723,3545,699,671Oct 28, 2020, 05:58 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 27, 2020Sale$33.03933,072994,073Oct 28, 2020, 05:58 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 19, 2020Sale$33.433,739124,9985,707,536Oct 20, 2020, 08:09 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 19, 2020Sale$33.4349416,515995,111Oct 20, 2020, 08:09 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 15, 2020Sale$33.032,47381,6945,718,972Oct 20, 2020, 08:09 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 15, 2020Sale$33.0332710,802996,621Oct 20, 2020, 08:09 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 16, 2020Sale$33.577,697258,4105,711,275Oct 20, 2020, 08:09 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 16, 2020Sale$33.571,01634,110995,605Oct 20, 2020, 08:09 PM
ALGSAligos Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 20, 2020Conversion-2,429,895-2,429,895Oct 20, 2020, 04:58 PM
ALGSAligos Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 20, 2020Conversion-662,444-662,444Oct 20, 2020, 04:58 PM
ALGSAligos Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 20, 2020Buy$15.00200,0003,000,000862,444Oct 20, 2020, 04:58 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 14, 2020Sale$33.094,859160,7875,721,445Oct 15, 2020, 07:22 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 14, 2020Sale$33.0964221,244996,948Oct 15, 2020, 07:22 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 13, 2020Sale$33.3910,370346,2715,726,304Oct 15, 2020, 07:22 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 13, 2020Sale$33.391,36945,713997,590Oct 15, 2020, 07:22 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 09, 2020Sale$33.6744314,914999,006Oct 13, 2020, 07:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 12, 2020Sale$33.1135311,6875,736,674Oct 13, 2020, 07:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 08, 2020Sale$33.4716,276544,8145,748,886Oct 13, 2020, 07:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 12, 2020Sale$33.11471,556998,959Oct 13, 2020, 07:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 08, 2020Sale$33.472,14971,9341,000,571Oct 13, 2020, 07:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 09, 2020Sale$33.673,357113,0185,737,027Oct 13, 2020, 07:41 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 07, 2020Sale$33.5624,590825,1545,756,660Oct 08, 2020, 07:14 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 07, 2020Sale$33.563,246108,9241,041,206Oct 08, 2020, 07:14 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 06, 2020Sale$33.2615,980531,4775,781,250Oct 08, 2020, 07:14 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerOct 06, 2020Sale$33.262,11070,1761,044,452Oct 08, 2020, 07:14 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 10, 2020Sale$33.0472523,9531,126,661Aug 12, 2020, 07:57 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 11, 2020Sale$33.086,692221,3806,797,230Aug 12, 2020, 07:57 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 11, 2020Sale$33.0888329,2111,125,778Aug 12, 2020, 07:57 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerAug 10, 2020Sale$33.045,492181,4466,803,922Aug 12, 2020, 07:57 PM
AKROAkero Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJan 07, 2020Sale$20.0514,162283,9482,885,836Jul 10, 2020, 08:28 PM
AKROAkero Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJan 08, 2020Sale$19.8022,368442,8862,863,468Jul 10, 2020, 08:28 PM
AKROAkero Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJan 09, 2020Sale$20.2116,527334,0112,846,941Jul 10, 2020, 08:28 PM
AKROAkero Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJan 06, 2020Sale$19.5453,3921,043,1022,948,422Jul 10, 2020, 08:28 PM
AKROAkero Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJan 02, 2020Sale$20.3615,852322,6853,645,633Jul 10, 2020, 08:28 PM
AKROAkero Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJan 03, 2020Sale$19.213,20061,4852,953,490Jul 10, 2020, 08:28 PM
PASGPassage BIO, Inc.Versant Venture Capital Vi, L.P.10% OwnerMar 03, 2020Conversion-4,026,417-4,026,417Mar 03, 2020, 07:03 PM
PASGPassage BIO, Inc.Versant Venture Capital Vi, L.P.10% OwnerMar 03, 2020Conversion-708,352-708,352Mar 03, 2020, 07:03 PM
PASGPassage BIO, Inc.Versant Venture Capital Vi, L.P.10% OwnerMar 03, 2020Buy$18.00225,0004,050,000933,352Mar 03, 2020, 07:03 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerFeb 03, 2020Buy$19.00498,6549,474,4262,209,592Feb 05, 2020, 06:02 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerFeb 03, 2020Conversion-6,081,747-6,413,332Feb 05, 2020, 06:02 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerFeb 03, 2020Buy$19.00396,0827,525,5586,809,414Feb 05, 2020, 06:02 PM
BDTXBlack Diamond Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerFeb 03, 2020Conversion-3,576,410-2,130,579Feb 05, 2020, 06:02 PM
AKROAkero Therapeutics, Inc.Versant Venture Capital Vi, L.P.10% OwnerJan 17, 2020Sale$20.0911,103223,0593,118,638Jan 21, 2020, 09:57 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe